Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AYP-101 for submental fat reduction
NCT03982225Phase 2Completed
- Sponsor
- AMIpharm
- Start
- Jul 2019
- Primary completion
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of polyene phosphatidylcholine in submental fat (4 arms), sponsored by AMIpharm. Primary endpoint: Percentage of Participants Who Achieved a Composite 1-grade Response with Clinician-Reported Submental Fat Rating Scale (CR-SMFRS) and Patient-Reported Submental Fat Rating Scale (PR-SMFRS). Started Jul 2019; status: completed.
02
Drugs
polyene phosphatidylcholine
03
Conditions
submental fat
Beyond the preview
Go deeper on NCT03982225.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03982225.